Article: No More Needles - A New Breakthrough for Iron Overload.

FRIMLEY, England, September 21 /PRNewswire-FirstCall/ -- - Exjade(R), a Breakthrough Once-Daily Oral Iron Chelator, Now Available in the UK

Novartis today announced the UK approval of Exjade(R) (deferasirox), the first and only once-daily oral iron chelator for the treatment of iron overload in patients needing frequent blood transfusions for genetic blood disorders such as thalassaemia, sickle cell disease and other rare anaemias. [1]

Iron chelation is often necessary for patients receiving frequent blood transfusions to prevent the potentially life-threatening complications of excess iron in the body.[2] If left untreated, iron overload can cause ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!